Pro Medicus Limited Stock: price and insider trades · Australia
Pro Medicus Limited: what insiders have been doing
Pro Medicus Limited belongs to the Health Care sector. Filings by its managers are published through ASX. 3 insiders have disclosed 3 filings since 28 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of Pro Medicus Limited has been absent for the past year.
Across the 1,606 companies tracked on its exchange, the median is 5 filings; at 3 filings, this issuer sits below that mark.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Analyst consensus: bullish or bearish?
Analysts rate Pro Medicus Limited Buy (bullish), based on 15 analysts. Average price target: A$202.61.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ●Unknown Substantial Holder0ASXShareASXISIN AU000000PME8ASX:2924-03154673-3A705244
- ShareASXISIN AU000000PME8ASX:2924-03132778-3A701231
- ShareASXISIN AU000000PME8ASX:2924-03095361-3A694326
3 of 3 declarations
About Pro Medicus Limited
Pro Medicus Limited is an Australian company specializing in software solutions for medical imaging. It provides tools to enhance the efficiency and quality of healthcare services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
